Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial
- Creator: Zdenkowski, N. , Forbes, J. F. , Mann, G. B. , Coates, A. S. , Gebski, V. , Davies, L. , Thornton, R. , Reaby, L. , Cuzick, J. , Green, M. , Boyle, F. M. , Kannourakis, G. , Gill, P. G. , Bayliss, E. , Saunders, C. , Della-Fiorentina, S. , Kling, N. , Campbell, I.
- Resource Type: journal article
- Date: 2016
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
- Creator: Coleman, R. , de Boer, R. , Frassoldati, A. , Campbell, I. , Paija, O. , Martin, N. , Modi, A. , Bundred, N. , Eidtmann, H. , Llombart, A. , Davidson, N. , Neven, P. , von Minckwitz, G. , Sleeboom, H. P. , Forbes, J. , Barrios, C.
- Resource Type: journal article
- Date: 2013